Structure Therapeutics Inc. - Common Stock (GPCR)

CUSIP: 86366E106

Q3 2024 13F Holders as of 30 Sep 2024

Holder snapshot 7 signals
Share change
+2,340,630
Put/Call ratio
80%
SEC-reported price per share
$43.89
Indexed holders
160
Value change
+$108,882,886
Number of buys
94
Open additional details 1 more signal available
Number of sells
66
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
215,359,875

Security key

86366E106

Report period

Q3 2024

Indexed institutions

160

Top holders

10

Ownership snapshot

Top reported holders of GPCR - Structure Therapeutics Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BVF PARTNERS L P/IL
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
0/15
Latest evidence
30 Jun 2024
3/4/5 13F Highest disclosed value: $296,406,819 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP has the largest disclosed position value at $296.41M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.
Disclosed position value Top 5
WELLINGTON MANAGEMENT GROUP LLP $296.41M
Janus Henderson Group Ltd. $131.65M
Capital Research Global Investors $122.97M
DRIEHAUS CAPITAL MANAGEMENT LLC $101.2M
BVF INC/IL $97.69M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BVF PARTNERS L P/IL
3/4/5
10%+ Owner
—
denominator unverified
—
462,605 shares
— 10 May 2023
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
—
denominator unverified
$296,406,819
7,547,920 shares
— 30 Jun 2024
Janus Henderson Group Ltd.
13F
Company
13F
—
denominator unverified
$131,649,761
3,354,269 shares
— 30 Jun 2024
Capital Research Global Investors
13F
Company
13F
—
denominator unverified
$122,966,544
3,131,310 shares
— 30 Jun 2024
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$101,204,131
2,577,136 shares
— 30 Jun 2024
BVF INC/IL
13F
Company
13F
—
denominator unverified
$97,694,414
2,487,762 shares
— 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
160
Shares
61,353,442
Indexed holders
160
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 indexed holders
164
Q3 2024 indexed holders
160
Indexed holder difference
-4
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .